Gut Microbiome Changes Persist Years After Colon Polyp Removal
Harvard researchers find lasting microbiome and metabolome shifts after adenoma resection that mirror colorectal cancer signatures.
Summary
A Harvard-led study examined stool samples from 354 women an average of 12 years after having precancerous colon polyps removed. Their gut microbiome profiles were distinctly different from matched controls — and strikingly similar to patterns seen in colorectal cancer patients. Key bacteria like Faecalibacterium prausnitzii were altered, along with 30 metabolites including sphingolipids. This suggests that people who've had adenomas removed carry a persistently altered gut environment that resembles the cancer-associated microbiome, even long after the polyps are gone. The findings raise the possibility that the gut microbiome is not just a bystander but an active participant in the progression from polyp to cancer.
Detailed Summary
Colorectal cancer (CRC) is one of the most common and preventable cancers, often developing through a well-defined sequence from benign polyps (adenomas) to malignancy. The gut microbiome is known to play a role in CRC, but whether microbial changes appear early — and persist — along this progression has remained unclear. This study provides some of the strongest evidence yet that they do.
Researchers from Harvard T.H. Chan School of Public Health profiled stool metagenomes from 354 women sampled an average of 12 years after adenoma resection, comparing them to 1:1 matched controls. Stool metabolomes were analyzed in 184 matched pairs. Metagenomic findings were then benchmarked against 14 independent CRC case-control datasets.
The gut microbial composition of adenoma cases differed significantly from controls and correlated with CRC-associated patterns (Pearson's rho = 0.26, p < 0.0001). Thirty-one specific microbes were altered in both adenoma and CRC conditions, including reductions in the beneficial anti-inflammatory bacterium Faecalibacterium prausnitzii. Metabolomically, 30 compounds and 7 biochemical sub-pathways — especially sphingolipids — were associated with adenoma history. Intriguing microbe-metabolite links emerged, including an association between Bilophila wadsworthia and alanine-containing dipeptides.
The clinical implications are significant. These findings suggest that adenoma resection does not fully reset the gut microbiome to a healthy baseline. A dysbiotic microbial environment may persist and potentially continue to drive cancer risk, even after successful polyp removal. This could inform post-polypectomy surveillance strategies and future microbiome-targeted interventions.
Caveats include that the study population is limited to women, which may restrict generalizability. The summary is based on the abstract only, so full methodological details, effect sizes, and sensitivity analyses are not available for assessment.
Key Findings
- Gut microbiome profiles remained altered 12+ years after adenoma removal, mirroring colorectal cancer signatures.
- 31 microbes, including Faecalibacterium prausnitzii, were dysregulated in both adenoma and CRC conditions.
- 30 fecal metabolites and 7 biochemical pathways, especially sphingolipids, were linked to adenoma history.
- Bilophila wadsworthia showed novel associations with alanine-containing dipeptides in adenoma cases.
- Microbial alterations correlated with lifestyle factors, suggesting modifiable risk pathways.
Methodology
Case-control study of 354 women with prior adenoma resection matched 1:1 to controls, with stool metagenomics and metabolomics assessed a mean of 12.1 years post-resection. Metagenomic findings were cross-validated against 14 independent CRC case-control datasets. Metabolomic analyses were conducted in a subset of 184 matched pairs.
Study Limitations
The study is limited to women, which may reduce generalizability to men and other populations. The summary is based on the abstract only, so full data, effect sizes, confounding adjustments, and subgroup analyses cannot be evaluated. Causal directionality between microbiome alterations and cancer progression cannot be established from this observational design.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.